These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 3348913)

  • 1. On the effect of Al(OH)3 as an immunological adjuvant.
    Majgaard Jensen O; Koch C
    APMIS; 1988 Mar; 96(3):257-64. PubMed ID: 3348913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Booster vaccination against diphtheria and tetanus in man. Comparison of three different vaccine formulations--III.
    Aggerbeck H; Wantzin J; Heron I
    Vaccine; 1996 Sep; 14(13):1265-72. PubMed ID: 8961516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid.
    Gupta RK; Siber GR
    Biologicals; 1994 Mar; 22(1):53-63. PubMed ID: 8068314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunization against neonatal tetanus in New Guinea.
    Hardegree MC; Barile MF; Pittman M; Schofield FD; Maclennan R; Kelly A
    Bull World Health Organ; 1970; 43(3):439-51. PubMed ID: 5312998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the adequate composition of diphtheria and tetanus toxoids-with reference to the amounts of toxoids and aluminum adjuvant.
    Someya S; Mizuhara H; Murata R; Kurokawa M
    Jpn J Med Sci Biol; 1981 Feb; 34(1):21-35. PubMed ID: 7265558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoglobulin E responses to diphtheria and tetanus toxoids after booster with aluminium-adsorbed and fluid DT-vaccines.
    Mark A; Björkstén B; Granström M
    Vaccine; 1995 May; 13(7):669-73. PubMed ID: 7668036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of tetanus toxoid formulation containing aluminium hydroxide adjuvant against freeze-thawing.
    Solanki VA; Jain NK; Roy I
    Int J Pharm; 2011 Jul; 414(1-2):140-7. PubMed ID: 21605644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on respiratory immunization with tetanus toxoid: the role of adjuvants.
    Bartlema HC; Braunius R; Hölscher L
    J Hyg (Lond); 1972 Dec; 70(4):627-38. PubMed ID: 4346009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoenhancement with combined rabies and aluminium-adjuvanted tetanus vaccines.
    Phanuphak P; Khaoplod P; Sriwanthana B; Phanpanich T; Wongurai S; Roumiantzeff M
    Vaccine; 1989 Jun; 7(3):249-52. PubMed ID: 2781858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on adjuvants for human prophylactics. II. Influence of the route of injection on the activity of adjuvants to tetanus toxoid in guinea pigs.
    Yamamoto A; Murata R
    Jpn J Med Sci Biol; 1978; 31(5-6):393-406. PubMed ID: 156804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Formulation of a potential antipregnancy vaccine based on the beta-subunit of human chorionic gonadotropin (beta-hCG). IV. The role of adjuvants in booster injections.
    Chang CC; Nash HA; Tsong YY
    J Reprod Immunol; 1986 Dec; 9(4):327-37. PubMed ID: 2434651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens.
    Gupta RK; Varanelli CL; Griffin P; Wallach DF; Siber GR
    Vaccine; 1996 Feb; 14(3):219-25. PubMed ID: 8920703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an animal model to assess the immunogenicity of single-dose tetanus and diphtheria vaccines based on controlled release from biodegradable polymer microspheres.
    Gupta RK; Griffin P; Rivera R; Siber GR
    Dev Biol Stand; 1998; 92():277-87. PubMed ID: 9554282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant/carrier activity of inactivated tick-borne encephalitis virus.
    Leibl H; Tomasits R; Eibl MM; Mannhalter JW
    Vaccine; 1998 Feb; 16(4):340-5. PubMed ID: 9607053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity in mice of anthrax recombinant protective antigen in the presence of aluminum adjuvants.
    Berthold I; Pombo ML; Wagner L; Arciniega JL
    Vaccine; 2005 Mar; 23(16):1993-9. PubMed ID: 15734073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid.
    Eastcott JW; Holmberg CJ; Dewhirst FE; Esch TR; Smith DJ; Taubman MA
    Vaccine; 2001 Feb; 19(13-14):1636-42. PubMed ID: 11166886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved immune response from biodegradable polymer particles entrapping tetanus toxoid by use of different immunization protocol and adjuvants.
    Raghuvanshi RS; Katare YK; Lalwani K; Ali MM; Singh O; Panda AK
    Int J Pharm; 2002 Oct; 245(1-2):109-21. PubMed ID: 12270248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunological evaluation of chitosan nanoparticles loaded with tetanus toxoid.
    Ghalavand M; Saadati M; Ahmadi A; Abbasi E; Salimian J
    Bratisl Lek Listy; 2018; 119(2):71-74. PubMed ID: 29455539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvanticity of aluminium hydroxide and calcium phosphate in diphtheria-tetanus vaccines--I.
    Aggerbeck H; Heron I
    Vaccine; 1995 Oct; 13(14):1360-5. PubMed ID: 8585294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aluminum salts in vaccines--US perspective.
    Baylor NW; Egan W; Richman P
    Vaccine; 2002 May; 20 Suppl 3():S18-23. PubMed ID: 12184360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.